Clinical Trial Update: Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study

View source ↗

Summary

A clinical trial from Queen Mary University of London aims to determine reference intervals for prostate-specific antigen (PSA) in transgender and non-binary in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Queen Mary University of London | Conditions: Prostate CA | Status: NOT_YET_RECRUITING